nodes	percent_of_prediction	percent_of_DWPC	metapath
Metformin—SLC22A1—hematologic cancer	0.146	1	CbGaD
Metformin—NDUFS7—Doxorubicin—hematologic cancer	0.0568	0.139	CbGbCtD
Metformin—NDUFS2—Doxorubicin—hematologic cancer	0.0568	0.139	CbGbCtD
Metformin—NDUFS3—Doxorubicin—hematologic cancer	0.0568	0.139	CbGbCtD
Metformin—SLC47A1—Imatinib—hematologic cancer	0.0397	0.0974	CbGbCtD
Metformin—SLC22A3—Melphalan—hematologic cancer	0.0383	0.0939	CbGbCtD
Metformin—SLC47A1—Mitoxantrone—hematologic cancer	0.0315	0.0773	CbGbCtD
Metformin—SLC22A2—Daunorubicin—hematologic cancer	0.016	0.0393	CbGbCtD
Metformin—SLC22A2—Cytarabine—hematologic cancer	0.0142	0.0347	CbGbCtD
Metformin—SLC22A2—Cladribine—hematologic cancer	0.0134	0.0328	CbGbCtD
Metformin—SLC22A3—Irinotecan—hematologic cancer	0.013	0.0318	CbGbCtD
Metformin—SLC22A1—Cytarabine—hematologic cancer	0.0123	0.0301	CbGbCtD
Metformin—SLC22A2—Imatinib—hematologic cancer	0.0123	0.0301	CbGbCtD
Metformin—SLC22A1—Cladribine—hematologic cancer	0.0116	0.0285	CbGbCtD
Metformin—SLC22A3—Vincristine—hematologic cancer	0.0113	0.0278	CbGbCtD
Metformin—SLC22A1—Imatinib—hematologic cancer	0.0107	0.0262	CbGbCtD
Metformin—SLC22A2—Vinblastine—hematologic cancer	0.00683	0.0167	CbGbCtD
Metformin—SLC22A2—Cisplatin—hematologic cancer	0.00626	0.0153	CbGbCtD
Metformin—NDUFAF3—testis—hematologic cancer	0.000559	0.00434	CbGeAlD
Metformin—NDUFA10—gonad—hematologic cancer	0.000549	0.00426	CbGeAlD
Metformin—NDUFB2—gonad—hematologic cancer	0.00054	0.00419	CbGeAlD
Metformin—ND6—gonad—hematologic cancer	0.000531	0.00412	CbGeAlD
Metformin—NDUFA9—lung—hematologic cancer	0.000531	0.00412	CbGeAlD
Metformin—NDUFA13—lung—hematologic cancer	0.000531	0.00412	CbGeAlD
Metformin—NDUFB3—gonad—hematologic cancer	0.000527	0.00409	CbGeAlD
Metformin—PRKAB1—hematopoietic system—hematologic cancer	0.000525	0.00407	CbGeAlD
Metformin—NDUFA1—lung—hematologic cancer	0.000523	0.00405	CbGeAlD
Metformin—NDUFA5—gonad—hematologic cancer	0.000515	0.00399	CbGeAlD
Metformin—ND5—bone marrow—hematologic cancer	0.000512	0.00397	CbGeAlD
Metformin—ND4L—bone marrow—hematologic cancer	0.000512	0.00397	CbGeAlD
Metformin—ND3—bone marrow—hematologic cancer	0.000512	0.00397	CbGeAlD
Metformin—ND2—bone marrow—hematologic cancer	0.000512	0.00397	CbGeAlD
Metformin—NDUFV2—lung—hematologic cancer	0.000507	0.00394	CbGeAlD
Metformin—NDUFS1—gonad—hematologic cancer	0.000507	0.00393	CbGeAlD
Metformin—NDUFB10—gonad—hematologic cancer	0.000503	0.0039	CbGeAlD
Metformin—NDUFA2—blood—hematologic cancer	0.000502	0.00389	CbGeAlD
Metformin—NDUFA9—testis—hematologic cancer	0.000501	0.00389	CbGeAlD
Metformin—NDUFA13—testis—hematologic cancer	0.000501	0.00389	CbGeAlD
Metformin—NDUFB7—gonad—hematologic cancer	0.0005	0.00388	CbGeAlD
Metformin—ND4—bone marrow—hematologic cancer	0.000496	0.00384	CbGeAlD
Metformin—NDUFC2—hematopoietic system—hematologic cancer	0.000495	0.00384	CbGeAlD
Metformin—NDUFA4L2—lung—hematologic cancer	0.000494	0.00383	CbGeAlD
Metformin—NDUFB5—gonad—hematologic cancer	0.00049	0.0038	CbGeAlD
Metformin—NDUFA6—gonad—hematologic cancer	0.00049	0.0038	CbGeAlD
Metformin—NDUFA2—bone marrow—hematologic cancer	0.000486	0.00377	CbGeAlD
Metformin—NDUFB4—gonad—hematologic cancer	0.00048	0.00372	CbGeAlD
Metformin—NDUFV2—testis—hematologic cancer	0.000479	0.00371	CbGeAlD
Metformin—NDUFA10—blood—hematologic cancer	0.000479	0.00371	CbGeAlD
Metformin—NDUFAB1—gonad—hematologic cancer	0.000477	0.0037	CbGeAlD
Metformin—NDUFS2—hematopoietic system—hematologic cancer	0.000476	0.00369	CbGeAlD
Metformin—NDUFC1—blood—hematologic cancer	0.000474	0.00368	CbGeAlD
Metformin—NDUFA8—gonad—hematologic cancer	0.000474	0.00368	CbGeAlD
Metformin—NDUFB9—gonad—hematologic cancer	0.000474	0.00368	CbGeAlD
Metformin—NDUFB2—blood—hematologic cancer	0.00047	0.00365	CbGeAlD
Metformin—NDUFS3—hematopoietic system—hematologic cancer	0.00047	0.00364	CbGeAlD
Metformin—NDUFV1—gonad—hematologic cancer	0.000468	0.00363	CbGeAlD
Metformin—NDUFAF1—blood—hematologic cancer	0.000466	0.00362	CbGeAlD
Metformin—NDUFS5—gonad—hematologic cancer	0.000466	0.00361	CbGeAlD
Metformin—NDUFB8—gonad—hematologic cancer	0.000466	0.00361	CbGeAlD
Metformin—NDUFA4L2—testis—hematologic cancer	0.000466	0.00361	CbGeAlD
Metformin—ND2—lung—hematologic cancer	0.000464	0.0036	CbGeAlD
Metformin—ND4L—lung—hematologic cancer	0.000464	0.0036	CbGeAlD
Metformin—ND5—lung—hematologic cancer	0.000464	0.0036	CbGeAlD
Metformin—ND3—lung—hematologic cancer	0.000464	0.0036	CbGeAlD
Metformin—NDUFA10—bone marrow—hematologic cancer	0.000463	0.00359	CbGeAlD
Metformin—ND6—blood—hematologic cancer	0.000463	0.00359	CbGeAlD
Metformin—NDUFC1—bone marrow—hematologic cancer	0.000459	0.00356	CbGeAlD
Metformin—NDUFB3—blood—hematologic cancer	0.000459	0.00356	CbGeAlD
Metformin—NDUFAF2—blood—hematologic cancer	0.000459	0.00356	CbGeAlD
Metformin—NDUFB2—bone marrow—hematologic cancer	0.000455	0.00353	CbGeAlD
Metformin—NDUFAF1—bone marrow—hematologic cancer	0.000451	0.0035	CbGeAlD
Metformin—ND4—lung—hematologic cancer	0.000449	0.00348	CbGeAlD
Metformin—NDUFA5—blood—hematologic cancer	0.000448	0.00348	CbGeAlD
Metformin—NDUFA11—blood—hematologic cancer	0.000448	0.00348	CbGeAlD
Metformin—ND6—bone marrow—hematologic cancer	0.000448	0.00347	CbGeAlD
Metformin—NDUFAF4—blood—hematologic cancer	0.000445	0.00345	CbGeAlD
Metformin—NDUFB6—blood—hematologic cancer	0.000445	0.00345	CbGeAlD
Metformin—NDUFAF2—bone marrow—hematologic cancer	0.000444	0.00344	CbGeAlD
Metformin—NDUFB3—bone marrow—hematologic cancer	0.000444	0.00344	CbGeAlD
Metformin—NDUFS1—blood—hematologic cancer	0.000442	0.00343	CbGeAlD
Metformin—NDUFA2—lung—hematologic cancer	0.00044	0.00341	CbGeAlD
Metformin—NDUFB10—blood—hematologic cancer	0.000439	0.0034	CbGeAlD
Metformin—ND4L—testis—hematologic cancer	0.000438	0.0034	CbGeAlD
Metformin—ND2—testis—hematologic cancer	0.000438	0.0034	CbGeAlD
Metformin—ND3—testis—hematologic cancer	0.000438	0.0034	CbGeAlD
Metformin—ND5—testis—hematologic cancer	0.000438	0.0034	CbGeAlD
Metformin—NDUFA12—blood—hematologic cancer	0.000435	0.00338	CbGeAlD
Metformin—NDUFB7—blood—hematologic cancer	0.000435	0.00338	CbGeAlD
Metformin—NDUFA7—lymph node—hematologic cancer	0.000434	0.00337	CbGeAlD
Metformin—NDUFA5—bone marrow—hematologic cancer	0.000434	0.00337	CbGeAlD
Metformin—NDUFB1—blood—hematologic cancer	0.000432	0.00335	CbGeAlD
Metformin—NDUFS8—blood—hematologic cancer	0.000432	0.00335	CbGeAlD
Metformin—NDUFAF4—bone marrow—hematologic cancer	0.000431	0.00334	CbGeAlD
Metformin—NDUFB6—bone marrow—hematologic cancer	0.000431	0.00334	CbGeAlD
Metformin—NDUFS1—bone marrow—hematologic cancer	0.000427	0.00332	CbGeAlD
Metformin—NDUFB5—blood—hematologic cancer	0.000427	0.00331	CbGeAlD
Metformin—NDUFA6—blood—hematologic cancer	0.000427	0.00331	CbGeAlD
Metformin—NDUFB10—bone marrow—hematologic cancer	0.000424	0.00329	CbGeAlD
Metformin—NDUFS4—blood—hematologic cancer	0.000424	0.00329	CbGeAlD
Metformin—ND4—testis—hematologic cancer	0.000424	0.00329	CbGeAlD
Metformin—NDUFB7—bone marrow—hematologic cancer	0.000421	0.00327	CbGeAlD
Metformin—NDUFA12—bone marrow—hematologic cancer	0.000421	0.00327	CbGeAlD
Metformin—NDUFA10—lung—hematologic cancer	0.00042	0.00326	CbGeAlD
Metformin—NDUFS8—bone marrow—hematologic cancer	0.000418	0.00325	CbGeAlD
Metformin—NDUFB1—bone marrow—hematologic cancer	0.000418	0.00325	CbGeAlD
Metformin—NDUFB4—blood—hematologic cancer	0.000418	0.00325	CbGeAlD
Metformin—NDUFC1—lung—hematologic cancer	0.000416	0.00323	CbGeAlD
Metformin—NDUFAB1—blood—hematologic cancer	0.000416	0.00323	CbGeAlD
Metformin—NDUFA2—testis—hematologic cancer	0.000415	0.00322	CbGeAlD
Metformin—NDUFB9—blood—hematologic cancer	0.000413	0.00321	CbGeAlD
Metformin—NDUFA8—blood—hematologic cancer	0.000413	0.00321	CbGeAlD
Metformin—NDUFB5—bone marrow—hematologic cancer	0.000413	0.0032	CbGeAlD
Metformin—NDUFA6—bone marrow—hematologic cancer	0.000413	0.0032	CbGeAlD
Metformin—NDUFB2—lung—hematologic cancer	0.000412	0.0032	CbGeAlD
Metformin—NDUFA4—blood—hematologic cancer	0.000411	0.00319	CbGeAlD
Metformin—NDUFS4—bone marrow—hematologic cancer	0.00041	0.00318	CbGeAlD
Metformin—NDUFAF1—lung—hematologic cancer	0.000409	0.00317	CbGeAlD
Metformin—NDUFV1—blood—hematologic cancer	0.000408	0.00317	CbGeAlD
Metformin—NDUFB11—blood—hematologic cancer	0.000408	0.00317	CbGeAlD
Metformin—NDUFS5—blood—hematologic cancer	0.000406	0.00315	CbGeAlD
Metformin—NDUFB8—blood—hematologic cancer	0.000406	0.00315	CbGeAlD
Metformin—ND6—lung—hematologic cancer	0.000406	0.00315	CbGeAlD
Metformin—NDUFB4—bone marrow—hematologic cancer	0.000405	0.00314	CbGeAlD
Metformin—NDUFB3—lung—hematologic cancer	0.000402	0.00312	CbGeAlD
Metformin—NDUFAF2—lung—hematologic cancer	0.000402	0.00312	CbGeAlD
Metformin—NDUFAB1—bone marrow—hematologic cancer	0.000402	0.00312	CbGeAlD
Metformin—NDUFB9—bone marrow—hematologic cancer	0.0004	0.0031	CbGeAlD
Metformin—NDUFA8—bone marrow—hematologic cancer	0.0004	0.0031	CbGeAlD
Metformin—PRKAB1—gonad—hematologic cancer	0.000399	0.0031	CbGeAlD
Metformin—NDUFA4—bone marrow—hematologic cancer	0.000397	0.00308	CbGeAlD
Metformin—NDUFA2—Podofilox—Teniposide—hematologic cancer	0.000397	0.102	CbGdCrCtD
Metformin—NDUFA10—testis—hematologic cancer	0.000396	0.00307	CbGeAlD
Metformin—NDUFB11—bone marrow—hematologic cancer	0.000395	0.00306	CbGeAlD
Metformin—NDUFV1—bone marrow—hematologic cancer	0.000395	0.00306	CbGeAlD
Metformin—NDUFA5—lung—hematologic cancer	0.000393	0.00305	CbGeAlD
Metformin—NDUFA11—lung—hematologic cancer	0.000393	0.00305	CbGeAlD
Metformin—NDUFS5—bone marrow—hematologic cancer	0.000393	0.00305	CbGeAlD
Metformin—NDUFB8—bone marrow—hematologic cancer	0.000393	0.00305	CbGeAlD
Metformin—NDUFC1—testis—hematologic cancer	0.000392	0.00304	CbGeAlD
Metformin—ND1—hematopoietic system—hematologic cancer	0.00039	0.00303	CbGeAlD
Metformin—NDUFAF4—lung—hematologic cancer	0.00039	0.00303	CbGeAlD
Metformin—NDUFB6—lung—hematologic cancer	0.00039	0.00303	CbGeAlD
Metformin—NDUFB2—testis—hematologic cancer	0.000389	0.00302	CbGeAlD
Metformin—NDUFS1—lung—hematologic cancer	0.000387	0.003	CbGeAlD
Metformin—NDUFAF1—testis—hematologic cancer	0.000386	0.00299	CbGeAlD
Metformin—NDUFB10—lung—hematologic cancer	0.000384	0.00298	CbGeAlD
Metformin—ND6—testis—hematologic cancer	0.000383	0.00297	CbGeAlD
Metformin—NDUFB7—lung—hematologic cancer	0.000382	0.00296	CbGeAlD
Metformin—NDUFA12—lung—hematologic cancer	0.000382	0.00296	CbGeAlD
Metformin—NDUFS7—blood—hematologic cancer	0.00038	0.00295	CbGeAlD
Metformin—NDUFAF2—testis—hematologic cancer	0.00038	0.00294	CbGeAlD
Metformin—NDUFB3—testis—hematologic cancer	0.00038	0.00294	CbGeAlD
Metformin—NDUFB1—lung—hematologic cancer	0.000379	0.00294	CbGeAlD
Metformin—NDUFS8—lung—hematologic cancer	0.000379	0.00294	CbGeAlD
Metformin—NDUFC2—gonad—hematologic cancer	0.000376	0.00292	CbGeAlD
Metformin—NDUFB5—lung—hematologic cancer	0.000374	0.0029	CbGeAlD
Metformin—NDUFA6—lung—hematologic cancer	0.000374	0.0029	CbGeAlD
Metformin—NDUFS4—lung—hematologic cancer	0.000372	0.00288	CbGeAlD
Metformin—NDUFA5—testis—hematologic cancer	0.000371	0.00288	CbGeAlD
Metformin—NDUFA11—testis—hematologic cancer	0.000371	0.00288	CbGeAlD
Metformin—NDUFB6—testis—hematologic cancer	0.000368	0.00286	CbGeAlD
Metformin—NDUFAF4—testis—hematologic cancer	0.000368	0.00286	CbGeAlD
Metformin—NDUFS7—bone marrow—hematologic cancer	0.000368	0.00285	CbGeAlD
Metformin—NDUFB4—lung—hematologic cancer	0.000367	0.00285	CbGeAlD
Metformin—NDUFS1—testis—hematologic cancer	0.000365	0.00283	CbGeAlD
Metformin—NDUFAB1—lung—hematologic cancer	0.000364	0.00283	CbGeAlD
Metformin—NDUFB10—testis—hematologic cancer	0.000363	0.00281	CbGeAlD
Metformin—NDUFB9—lung—hematologic cancer	0.000362	0.00281	CbGeAlD
Metformin—NDUFA8—lung—hematologic cancer	0.000362	0.00281	CbGeAlD
Metformin—NDUFS2—gonad—hematologic cancer	0.000362	0.00281	CbGeAlD
Metformin—NDUFA12—testis—hematologic cancer	0.00036	0.00279	CbGeAlD
Metformin—NDUFB7—testis—hematologic cancer	0.00036	0.00279	CbGeAlD
Metformin—NDUFA4—lung—hematologic cancer	0.00036	0.00279	CbGeAlD
Metformin—NDUFV1—lung—hematologic cancer	0.000358	0.00278	CbGeAlD
Metformin—NDUFB11—lung—hematologic cancer	0.000358	0.00278	CbGeAlD
Metformin—NDUFB1—testis—hematologic cancer	0.000358	0.00277	CbGeAlD
Metformin—NDUFS8—testis—hematologic cancer	0.000358	0.00277	CbGeAlD
Metformin—NDUFS3—gonad—hematologic cancer	0.000357	0.00277	CbGeAlD
Metformin—NDUFS5—lung—hematologic cancer	0.000356	0.00276	CbGeAlD
Metformin—NDUFB8—lung—hematologic cancer	0.000356	0.00276	CbGeAlD
Metformin—NDUFA5—Menadione—Thalidomide—hematologic cancer	0.000354	0.0905	CbGdCrCtD
Metformin—NDUFA6—testis—hematologic cancer	0.000353	0.00274	CbGeAlD
Metformin—NDUFB5—testis—hematologic cancer	0.000353	0.00274	CbGeAlD
Metformin—NDUFS4—testis—hematologic cancer	0.000351	0.00272	CbGeAlD
Metformin—PRKAB1—blood—hematologic cancer	0.000348	0.0027	CbGeAlD
Metformin—NDUFV2—lymph node—hematologic cancer	0.000347	0.00269	CbGeAlD
Metformin—NDUFB4—testis—hematologic cancer	0.000346	0.00268	CbGeAlD
Metformin—NDUFAB1—testis—hematologic cancer	0.000344	0.00267	CbGeAlD
Metformin—NDUFB9—testis—hematologic cancer	0.000342	0.00265	CbGeAlD
Metformin—NDUFA8—testis—hematologic cancer	0.000342	0.00265	CbGeAlD
Metformin—NDUFA4—testis—hematologic cancer	0.00034	0.00264	CbGeAlD
Metformin—NDUFV1—testis—hematologic cancer	0.000338	0.00262	CbGeAlD
Metformin—NDUFB11—testis—hematologic cancer	0.000338	0.00262	CbGeAlD
Metformin—NDUFA4L2—lymph node—hematologic cancer	0.000338	0.00262	CbGeAlD
Metformin—PRKAB1—bone marrow—hematologic cancer	0.000337	0.00261	CbGeAlD
Metformin—NDUFB8—testis—hematologic cancer	0.000336	0.0026	CbGeAlD
Metformin—NDUFS5—testis—hematologic cancer	0.000336	0.0026	CbGeAlD
Metformin—NDUFS7—lung—hematologic cancer	0.000333	0.00259	CbGeAlD
Metformin—NDUFC2—blood—hematologic cancer	0.000328	0.00254	CbGeAlD
Metformin—ND4L—lymph node—hematologic cancer	0.000317	0.00246	CbGeAlD
Metformin—ND5—lymph node—hematologic cancer	0.000317	0.00246	CbGeAlD
Metformin—ND3—lymph node—hematologic cancer	0.000317	0.00246	CbGeAlD
Metformin—ND2—lymph node—hematologic cancer	0.000317	0.00246	CbGeAlD
Metformin—NDUFC2—bone marrow—hematologic cancer	0.000317	0.00246	CbGeAlD
Metformin—NDUFS2—blood—hematologic cancer	0.000315	0.00244	CbGeAlD
Metformin—NDUFS7—testis—hematologic cancer	0.000315	0.00244	CbGeAlD
Metformin—NDUFS3—blood—hematologic cancer	0.000311	0.00241	CbGeAlD
Metformin—ND4—lymph node—hematologic cancer	0.000307	0.00238	CbGeAlD
Metformin—PRKAB1—lung—hematologic cancer	0.000305	0.00237	CbGeAlD
Metformin—NDUFS2—bone marrow—hematologic cancer	0.000305	0.00237	CbGeAlD
Metformin—NDUFS3—bone marrow—hematologic cancer	0.000301	0.00234	CbGeAlD
Metformin—NDUFA2—lymph node—hematologic cancer	0.000301	0.00233	CbGeAlD
Metformin—ND1—gonad—hematologic cancer	0.000297	0.0023	CbGeAlD
Metformin—PRKAB1—testis—hematologic cancer	0.000288	0.00223	CbGeAlD
Metformin—NDUFC2—lung—hematologic cancer	0.000287	0.00223	CbGeAlD
Metformin—NDUFA10—lymph node—hematologic cancer	0.000287	0.00223	CbGeAlD
Metformin—NDUFC1—lymph node—hematologic cancer	0.000284	0.00221	CbGeAlD
Metformin—NDUFB2—lymph node—hematologic cancer	0.000282	0.00219	CbGeAlD
Metformin—NDUFAF1—lymph node—hematologic cancer	0.00028	0.00217	CbGeAlD
Metformin—ND6—lymph node—hematologic cancer	0.000277	0.00215	CbGeAlD
Metformin—NDUFS2—lung—hematologic cancer	0.000276	0.00214	CbGeAlD
Metformin—NDUFAF2—lymph node—hematologic cancer	0.000275	0.00213	CbGeAlD
Metformin—NDUFB3—lymph node—hematologic cancer	0.000275	0.00213	CbGeAlD
Metformin—NDUFS3—lung—hematologic cancer	0.000273	0.00212	CbGeAlD
Metformin—NDUFC2—testis—hematologic cancer	0.000271	0.0021	CbGeAlD
Metformin—NDUFA5—lymph node—hematologic cancer	0.000269	0.00209	CbGeAlD
Metformin—NDUFA11—lymph node—hematologic cancer	0.000269	0.00209	CbGeAlD
Metformin—NDUFAF4—lymph node—hematologic cancer	0.000267	0.00207	CbGeAlD
Metformin—NDUFB6—lymph node—hematologic cancer	0.000267	0.00207	CbGeAlD
Metformin—SLC47A1—hematopoietic system—hematologic cancer	0.000265	0.00206	CbGeAlD
Metformin—NDUFS1—lymph node—hematologic cancer	0.000265	0.00205	CbGeAlD
Metformin—NDUFB10—lymph node—hematologic cancer	0.000263	0.00204	CbGeAlD
Metformin—NDUFA12—lymph node—hematologic cancer	0.000261	0.00203	CbGeAlD
Metformin—NDUFB7—lymph node—hematologic cancer	0.000261	0.00203	CbGeAlD
Metformin—NDUFS2—testis—hematologic cancer	0.000261	0.00202	CbGeAlD
Metformin—NDUFS8—lymph node—hematologic cancer	0.000259	0.00201	CbGeAlD
Metformin—NDUFB1—lymph node—hematologic cancer	0.000259	0.00201	CbGeAlD
Metformin—NDUFS3—testis—hematologic cancer	0.000257	0.002	CbGeAlD
Metformin—NDUFA6—lymph node—hematologic cancer	0.000256	0.00198	CbGeAlD
Metformin—NDUFB5—lymph node—hematologic cancer	0.000256	0.00198	CbGeAlD
Metformin—NDUFS4—lymph node—hematologic cancer	0.000254	0.00197	CbGeAlD
Metformin—NDUFA2—Vincristine—Vinorelbine—hematologic cancer	0.000253	0.0646	CbGdCrCtD
Metformin—NDUFB4—lymph node—hematologic cancer	0.000251	0.00195	CbGeAlD
Metformin—ND1—bone marrow—hematologic cancer	0.00025	0.00194	CbGeAlD
Metformin—NDUFAB1—lymph node—hematologic cancer	0.000249	0.00193	CbGeAlD
Metformin—NDUFB9—lymph node—hematologic cancer	0.000248	0.00192	CbGeAlD
Metformin—NDUFA8—lymph node—hematologic cancer	0.000248	0.00192	CbGeAlD
Metformin—NDUFA4—lymph node—hematologic cancer	0.000246	0.00191	CbGeAlD
Metformin—NDUFV1—lymph node—hematologic cancer	0.000245	0.0019	CbGeAlD
Metformin—NDUFB11—lymph node—hematologic cancer	0.000245	0.0019	CbGeAlD
Metformin—NDUFB8—lymph node—hematologic cancer	0.000243	0.00189	CbGeAlD
Metformin—NDUFS5—lymph node—hematologic cancer	0.000243	0.00189	CbGeAlD
Metformin—NDUFA2—Podofilox—Etoposide—hematologic cancer	0.000236	0.0604	CbGdCrCtD
Metformin—NDUFS7—lymph node—hematologic cancer	0.000228	0.00177	CbGeAlD
Metformin—ND1—lung—hematologic cancer	0.000227	0.00176	CbGeAlD
Metformin—ND1—testis—hematologic cancer	0.000214	0.00166	CbGeAlD
Metformin—SLC22A3—hematopoietic system—hematologic cancer	0.000211	0.00164	CbGeAlD
Metformin—PRKAB1—lymph node—hematologic cancer	0.000209	0.00162	CbGeAlD
Metformin—NDUFA2—Vincristine—Vinblastine—hematologic cancer	0.000202	0.0517	CbGdCrCtD
Metformin—SLC47A1—gonad—hematologic cancer	0.000202	0.00156	CbGeAlD
Metformin—NDUFC2—lymph node—hematologic cancer	0.000197	0.00152	CbGeAlD
Metformin—NDUFS2—lymph node—hematologic cancer	0.000189	0.00147	CbGeAlD
Metformin—NDUFS3—lymph node—hematologic cancer	0.000187	0.00145	CbGeAlD
Metformin—NDUFA7—Azacitidine—Pentostatin—hematologic cancer	0.000181	0.0463	CbGdCrCtD
Metformin—SLC47A1—blood—hematologic cancer	0.000176	0.00136	CbGeAlD
Metformin—NDUFA7—Azacitidine—Clofarabine—hematologic cancer	0.000162	0.0413	CbGdCrCtD
Metformin—SLC22A3—gonad—hematologic cancer	0.000161	0.00125	CbGeAlD
Metformin—ND1—lymph node—hematologic cancer	0.000155	0.0012	CbGeAlD
Metformin—NDUFA2—Azacitidine—Pentostatin—hematologic cancer	0.000154	0.0394	CbGdCrCtD
Metformin—SLC47A1—lung—hematologic cancer	0.000154	0.00119	CbGeAlD
Metformin—NDUFA7—Azacitidine—Nelarabine—hematologic cancer	0.000152	0.0388	CbGdCrCtD
Metformin—SLC22A1—blood—hematologic cancer	0.000147	0.00114	CbGeAlD
Metformin—SLC47A1—testis—hematologic cancer	0.000145	0.00113	CbGeAlD
Metformin—NDUFB3—Azacitidine—Pentostatin—hematologic cancer	0.000137	0.0351	CbGdCrCtD
Metformin—NDUFA2—Azacitidine—Clofarabine—hematologic cancer	0.000137	0.0351	CbGdCrCtD
Metformin—NDUFA2—Azacitidine—Nelarabine—hematologic cancer	0.000129	0.033	CbGdCrCtD
Metformin—SLC22A3—lung—hematologic cancer	0.000123	0.000952	CbGeAlD
Metformin—NDUFB3—Azacitidine—Clofarabine—hematologic cancer	0.000122	0.0313	CbGdCrCtD
Metformin—NDUFA7—Azacitidine—Fludarabine—hematologic cancer	0.000119	0.0303	CbGdCrCtD
Metformin—SLC22A3—testis—hematologic cancer	0.000116	0.000899	CbGeAlD
Metformin—NDUFB3—Azacitidine—Nelarabine—hematologic cancer	0.000115	0.0294	CbGdCrCtD
Metformin—NDUFA7—Azacitidine—Cytarabine—hematologic cancer	0.000112	0.0286	CbGdCrCtD
Metformin—NDUFA7—Azacitidine—Gemcitabine—hematologic cancer	0.000112	0.0286	CbGdCrCtD
Metformin—NDUFA7—Azacitidine—Cladribine—hematologic cancer	0.000109	0.0279	CbGdCrCtD
Metformin—SLC47A1—lymph node—hematologic cancer	0.000105	0.000817	CbGeAlD
Metformin—NDUFA2—Azacitidine—Fludarabine—hematologic cancer	0.000101	0.0258	CbGdCrCtD
Metformin—NDUFA2—Azacitidine—Cytarabine—hematologic cancer	9.52e-05	0.0243	CbGdCrCtD
Metformin—NDUFA2—Azacitidine—Gemcitabine—hematologic cancer	9.52e-05	0.0243	CbGdCrCtD
Metformin—NDUFA2—Azacitidine—Cladribine—hematologic cancer	9.28e-05	0.0237	CbGdCrCtD
Metformin—NDUFB3—Azacitidine—Fludarabine—hematologic cancer	8.98e-05	0.023	CbGdCrCtD
Metformin—NDUFB3—Azacitidine—Cytarabine—hematologic cancer	8.48e-05	0.0217	CbGdCrCtD
Metformin—NDUFB3—Azacitidine—Gemcitabine—hematologic cancer	8.48e-05	0.0217	CbGdCrCtD
Metformin—SLC22A3—lymph node—hematologic cancer	8.4e-05	0.000651	CbGeAlD
Metformin—NDUFB3—Azacitidine—Cladribine—hematologic cancer	8.27e-05	0.0211	CbGdCrCtD
Metformin—Bradycardia—Doxorubicin—hematologic cancer	2.61e-05	0.000145	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	2.61e-05	0.000145	CcSEcCtD
Metformin—Paraesthesia—Dexamethasone—hematologic cancer	2.59e-05	0.000145	CcSEcCtD
Metformin—Paraesthesia—Betamethasone—hematologic cancer	2.59e-05	0.000145	CcSEcCtD
Metformin—Discomfort—Prednisone—hematologic cancer	2.59e-05	0.000145	CcSEcCtD
Metformin—Rash—Gemcitabine—hematologic cancer	2.59e-05	0.000145	CcSEcCtD
Metformin—Dermatitis—Gemcitabine—hematologic cancer	2.59e-05	0.000144	CcSEcCtD
Metformin—Eye disorder—Epirubicin—hematologic cancer	2.59e-05	0.000144	CcSEcCtD
Metformin—Malnutrition—Methotrexate—hematologic cancer	2.58e-05	0.000144	CcSEcCtD
Metformin—Erythema—Methotrexate—hematologic cancer	2.58e-05	0.000144	CcSEcCtD
Metformin—Headache—Gemcitabine—hematologic cancer	2.58e-05	0.000144	CcSEcCtD
Metformin—Nausea—Vincristine—hematologic cancer	2.57e-05	0.000144	CcSEcCtD
Metformin—Cardiac disorder—Epirubicin—hematologic cancer	2.57e-05	0.000143	CcSEcCtD
Metformin—Flushing—Epirubicin—hematologic cancer	2.57e-05	0.000143	CcSEcCtD
Metformin—Rhinitis—Doxorubicin—hematologic cancer	2.57e-05	0.000143	CcSEcCtD
Metformin—Hepatitis—Doxorubicin—hematologic cancer	2.56e-05	0.000143	CcSEcCtD
Metformin—Hypoaesthesia—Doxorubicin—hematologic cancer	2.55e-05	0.000142	CcSEcCtD
Metformin—Dyspepsia—Betamethasone—hematologic cancer	2.54e-05	0.000142	CcSEcCtD
Metformin—Dyspepsia—Dexamethasone—hematologic cancer	2.54e-05	0.000142	CcSEcCtD
Metformin—Urticaria—Triamcinolone—hematologic cancer	2.53e-05	0.000141	CcSEcCtD
Metformin—Oedema peripheral—Doxorubicin—hematologic cancer	2.52e-05	0.000141	CcSEcCtD
Metformin—Dysgeusia—Methotrexate—hematologic cancer	2.52e-05	0.000141	CcSEcCtD
Metformin—Asthenia—Etoposide—hematologic cancer	2.52e-05	0.00014	CcSEcCtD
Metformin—Connective tissue disorder—Doxorubicin—hematologic cancer	2.52e-05	0.00014	CcSEcCtD
Metformin—Oedema—Prednisone—hematologic cancer	2.52e-05	0.00014	CcSEcCtD
Metformin—Angiopathy—Epirubicin—hematologic cancer	2.51e-05	0.00014	CcSEcCtD
Metformin—Decreased appetite—Dexamethasone—hematologic cancer	2.51e-05	0.00014	CcSEcCtD
Metformin—Decreased appetite—Betamethasone—hematologic cancer	2.51e-05	0.00014	CcSEcCtD
Metformin—Nausea—Mitoxantrone—hematologic cancer	2.51e-05	0.00014	CcSEcCtD
Metformin—Nausea—Irinotecan—hematologic cancer	2.51e-05	0.00014	CcSEcCtD
Metformin—Immune system disorder—Epirubicin—hematologic cancer	2.5e-05	0.000139	CcSEcCtD
Metformin—Infection—Prednisone—hematologic cancer	2.5e-05	0.000139	CcSEcCtD
Metformin—Mediastinal disorder—Epirubicin—hematologic cancer	2.5e-05	0.000139	CcSEcCtD
Metformin—Gastrointestinal disorder—Betamethasone—hematologic cancer	2.49e-05	0.000139	CcSEcCtD
Metformin—Gastrointestinal disorder—Dexamethasone—hematologic cancer	2.49e-05	0.000139	CcSEcCtD
Metformin—Fatigue—Dexamethasone—hematologic cancer	2.49e-05	0.000139	CcSEcCtD
Metformin—Fatigue—Betamethasone—hematologic cancer	2.49e-05	0.000139	CcSEcCtD
Metformin—Chills—Epirubicin—hematologic cancer	2.49e-05	0.000139	CcSEcCtD
Metformin—Pruritus—Etoposide—hematologic cancer	2.48e-05	0.000138	CcSEcCtD
Metformin—Shock—Prednisone—hematologic cancer	2.48e-05	0.000138	CcSEcCtD
Metformin—Nervous system disorder—Prednisone—hematologic cancer	2.47e-05	0.000138	CcSEcCtD
Metformin—Skin disorder—Prednisone—hematologic cancer	2.44e-05	0.000136	CcSEcCtD
Metformin—Nausea—Gemcitabine—hematologic cancer	2.44e-05	0.000136	CcSEcCtD
Metformin—Vomiting—Cisplatin—hematologic cancer	2.44e-05	0.000136	CcSEcCtD
Metformin—Hyperhidrosis—Prednisone—hematologic cancer	2.43e-05	0.000136	CcSEcCtD
Metformin—Vision blurred—Methotrexate—hematologic cancer	2.43e-05	0.000135	CcSEcCtD
Metformin—Rash—Cisplatin—hematologic cancer	2.42e-05	0.000135	CcSEcCtD
Metformin—Dermatitis—Cisplatin—hematologic cancer	2.41e-05	0.000135	CcSEcCtD
Metformin—Erythema—Epirubicin—hematologic cancer	2.41e-05	0.000134	CcSEcCtD
Metformin—Malnutrition—Epirubicin—hematologic cancer	2.41e-05	0.000134	CcSEcCtD
Metformin—Diarrhoea—Etoposide—hematologic cancer	2.4e-05	0.000134	CcSEcCtD
Metformin—Anorexia—Prednisone—hematologic cancer	2.4e-05	0.000134	CcSEcCtD
Metformin—Eye disorder—Doxorubicin—hematologic cancer	2.39e-05	0.000134	CcSEcCtD
Metformin—Ill-defined disorder—Methotrexate—hematologic cancer	2.39e-05	0.000133	CcSEcCtD
Metformin—Feeling abnormal—Betamethasone—hematologic cancer	2.38e-05	0.000133	CcSEcCtD
Metformin—Feeling abnormal—Dexamethasone—hematologic cancer	2.38e-05	0.000133	CcSEcCtD
Metformin—Flushing—Doxorubicin—hematologic cancer	2.38e-05	0.000133	CcSEcCtD
Metformin—Cardiac disorder—Doxorubicin—hematologic cancer	2.38e-05	0.000133	CcSEcCtD
Metformin—Flatulence—Epirubicin—hematologic cancer	2.38e-05	0.000132	CcSEcCtD
Metformin—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.36e-05	0.000132	CcSEcCtD
Metformin—Gastrointestinal pain—Betamethasone—hematologic cancer	2.36e-05	0.000132	CcSEcCtD
Metformin—Dysgeusia—Epirubicin—hematologic cancer	2.36e-05	0.000132	CcSEcCtD
Metformin—Angiopathy—Doxorubicin—hematologic cancer	2.33e-05	0.00013	CcSEcCtD
Metformin—Malaise—Methotrexate—hematologic cancer	2.32e-05	0.00013	CcSEcCtD
Metformin—Dizziness—Etoposide—hematologic cancer	2.32e-05	0.000129	CcSEcCtD
Metformin—Muscle spasms—Epirubicin—hematologic cancer	2.32e-05	0.000129	CcSEcCtD
Metformin—Immune system disorder—Doxorubicin—hematologic cancer	2.31e-05	0.000129	CcSEcCtD
Metformin—Mediastinal disorder—Doxorubicin—hematologic cancer	2.31e-05	0.000129	CcSEcCtD
Metformin—Chills—Doxorubicin—hematologic cancer	2.3e-05	0.000128	CcSEcCtD
Metformin—Urticaria—Dexamethasone—hematologic cancer	2.3e-05	0.000128	CcSEcCtD
Metformin—Urticaria—Betamethasone—hematologic cancer	2.3e-05	0.000128	CcSEcCtD
Metformin—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.29e-05	0.000128	CcSEcCtD
Metformin—Dizziness—Prednisolone—hematologic cancer	2.29e-05	0.000128	CcSEcCtD
Metformin—Asthenia—Triamcinolone—hematologic cancer	2.28e-05	0.000127	CcSEcCtD
Metformin—Abdominal pain—Betamethasone—hematologic cancer	2.28e-05	0.000127	CcSEcCtD
Metformin—Abdominal pain—Dexamethasone—hematologic cancer	2.28e-05	0.000127	CcSEcCtD
Metformin—Nausea—Cisplatin—hematologic cancer	2.28e-05	0.000127	CcSEcCtD
Metformin—Vision blurred—Epirubicin—hematologic cancer	2.27e-05	0.000127	CcSEcCtD
Metformin—Paraesthesia—Prednisone—hematologic cancer	2.26e-05	0.000126	CcSEcCtD
Metformin—Pruritus—Triamcinolone—hematologic cancer	2.25e-05	0.000126	CcSEcCtD
Metformin—Ill-defined disorder—Epirubicin—hematologic cancer	2.24e-05	0.000125	CcSEcCtD
Metformin—Vomiting—Etoposide—hematologic cancer	2.23e-05	0.000124	CcSEcCtD
Metformin—Erythema—Doxorubicin—hematologic cancer	2.23e-05	0.000124	CcSEcCtD
Metformin—Malnutrition—Doxorubicin—hematologic cancer	2.23e-05	0.000124	CcSEcCtD
Metformin—Dyspepsia—Prednisone—hematologic cancer	2.21e-05	0.000123	CcSEcCtD
Metformin—Rash—Etoposide—hematologic cancer	2.21e-05	0.000123	CcSEcCtD
Metformin—Dermatitis—Etoposide—hematologic cancer	2.21e-05	0.000123	CcSEcCtD
Metformin—Headache—Etoposide—hematologic cancer	2.2e-05	0.000123	CcSEcCtD
Metformin—Flatulence—Doxorubicin—hematologic cancer	2.2e-05	0.000123	CcSEcCtD
Metformin—Myalgia—Methotrexate—hematologic cancer	2.19e-05	0.000122	CcSEcCtD
Metformin—Chest pain—Methotrexate—hematologic cancer	2.19e-05	0.000122	CcSEcCtD
Metformin—Decreased appetite—Prednisone—hematologic cancer	2.19e-05	0.000122	CcSEcCtD
Metformin—Dysgeusia—Doxorubicin—hematologic cancer	2.18e-05	0.000122	CcSEcCtD
Metformin—Rash—Prednisolone—hematologic cancer	2.18e-05	0.000122	CcSEcCtD
Metformin—Dermatitis—Prednisolone—hematologic cancer	2.18e-05	0.000122	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	2.18e-05	0.000121	CcSEcCtD
Metformin—Malaise—Epirubicin—hematologic cancer	2.17e-05	0.000121	CcSEcCtD
Metformin—Fatigue—Prednisone—hematologic cancer	2.17e-05	0.000121	CcSEcCtD
Metformin—Headache—Prednisolone—hematologic cancer	2.17e-05	0.000121	CcSEcCtD
Metformin—Discomfort—Methotrexate—hematologic cancer	2.17e-05	0.000121	CcSEcCtD
Metformin—Syncope—Epirubicin—hematologic cancer	2.16e-05	0.000121	CcSEcCtD
Metformin—Constipation—Prednisone—hematologic cancer	2.15e-05	0.00012	CcSEcCtD
Metformin—Muscle spasms—Doxorubicin—hematologic cancer	2.14e-05	0.00012	CcSEcCtD
Metformin—Palpitations—Epirubicin—hematologic cancer	2.13e-05	0.000119	CcSEcCtD
Metformin—Loss of consciousness—Epirubicin—hematologic cancer	2.12e-05	0.000118	CcSEcCtD
Metformin—Dizziness—Triamcinolone—hematologic cancer	2.11e-05	0.000117	CcSEcCtD
Metformin—Vision blurred—Doxorubicin—hematologic cancer	2.1e-05	0.000117	CcSEcCtD
Metformin—Infection—Methotrexate—hematologic cancer	2.09e-05	0.000116	CcSEcCtD
Metformin—Nausea—Etoposide—hematologic cancer	2.09e-05	0.000116	CcSEcCtD
Metformin—Hypertension—Epirubicin—hematologic cancer	2.08e-05	0.000116	CcSEcCtD
Metformin—Feeling abnormal—Prednisone—hematologic cancer	2.07e-05	0.000116	CcSEcCtD
Metformin—Asthenia—Dexamethasone—hematologic cancer	2.07e-05	0.000116	CcSEcCtD
Metformin—Asthenia—Betamethasone—hematologic cancer	2.07e-05	0.000116	CcSEcCtD
Metformin—Ill-defined disorder—Doxorubicin—hematologic cancer	2.07e-05	0.000115	CcSEcCtD
Metformin—Nervous system disorder—Methotrexate—hematologic cancer	2.06e-05	0.000115	CcSEcCtD
Metformin—Thrombocytopenia—Methotrexate—hematologic cancer	2.06e-05	0.000115	CcSEcCtD
Metformin—Gastrointestinal pain—Prednisone—hematologic cancer	2.06e-05	0.000115	CcSEcCtD
Metformin—Nausea—Prednisolone—hematologic cancer	2.06e-05	0.000115	CcSEcCtD
Metformin—Myalgia—Epirubicin—hematologic cancer	2.05e-05	0.000114	CcSEcCtD
Metformin—Chest pain—Epirubicin—hematologic cancer	2.05e-05	0.000114	CcSEcCtD
Metformin—Pruritus—Betamethasone—hematologic cancer	2.04e-05	0.000114	CcSEcCtD
Metformin—Pruritus—Dexamethasone—hematologic cancer	2.04e-05	0.000114	CcSEcCtD
Metformin—Skin disorder—Methotrexate—hematologic cancer	2.04e-05	0.000114	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.04e-05	0.000114	CcSEcCtD
Metformin—Hyperhidrosis—Methotrexate—hematologic cancer	2.03e-05	0.000113	CcSEcCtD
Metformin—Discomfort—Epirubicin—hematologic cancer	2.03e-05	0.000113	CcSEcCtD
Metformin—Vomiting—Triamcinolone—hematologic cancer	2.02e-05	0.000113	CcSEcCtD
Metformin—Malaise—Doxorubicin—hematologic cancer	2.01e-05	0.000112	CcSEcCtD
Metformin—Rash—Triamcinolone—hematologic cancer	2.01e-05	0.000112	CcSEcCtD
Metformin—Dermatitis—Triamcinolone—hematologic cancer	2.01e-05	0.000112	CcSEcCtD
Metformin—Anorexia—Methotrexate—hematologic cancer	2e-05	0.000112	CcSEcCtD
Metformin—Syncope—Doxorubicin—hematologic cancer	2e-05	0.000112	CcSEcCtD
Metformin—Urticaria—Prednisone—hematologic cancer	2e-05	0.000111	CcSEcCtD
Metformin—Headache—Triamcinolone—hematologic cancer	1.99e-05	0.000111	CcSEcCtD
Metformin—Abdominal pain—Prednisone—hematologic cancer	1.99e-05	0.000111	CcSEcCtD
Metformin—Diarrhoea—Dexamethasone—hematologic cancer	1.98e-05	0.00011	CcSEcCtD
Metformin—Diarrhoea—Betamethasone—hematologic cancer	1.98e-05	0.00011	CcSEcCtD
Metformin—Palpitations—Doxorubicin—hematologic cancer	1.97e-05	0.00011	CcSEcCtD
Metformin—Oedema—Epirubicin—hematologic cancer	1.97e-05	0.00011	CcSEcCtD
Metformin—Hypotension—Methotrexate—hematologic cancer	1.96e-05	0.00011	CcSEcCtD
Metformin—Loss of consciousness—Doxorubicin—hematologic cancer	1.96e-05	0.000109	CcSEcCtD
Metformin—Infection—Epirubicin—hematologic cancer	1.95e-05	0.000109	CcSEcCtD
Metformin—Shock—Epirubicin—hematologic cancer	1.94e-05	0.000108	CcSEcCtD
Metformin—Nervous system disorder—Epirubicin—hematologic cancer	1.93e-05	0.000108	CcSEcCtD
Metformin—Thrombocytopenia—Epirubicin—hematologic cancer	1.93e-05	0.000107	CcSEcCtD
Metformin—Hypertension—Doxorubicin—hematologic cancer	1.93e-05	0.000107	CcSEcCtD
Metformin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.92e-05	0.000107	CcSEcCtD
Metformin—Skin disorder—Epirubicin—hematologic cancer	1.91e-05	0.000107	CcSEcCtD
Metformin—Dizziness—Betamethasone—hematologic cancer	1.91e-05	0.000107	CcSEcCtD
Metformin—Dizziness—Dexamethasone—hematologic cancer	1.91e-05	0.000107	CcSEcCtD
Metformin—Hyperhidrosis—Epirubicin—hematologic cancer	1.9e-05	0.000106	CcSEcCtD
Metformin—Chest pain—Doxorubicin—hematologic cancer	1.9e-05	0.000106	CcSEcCtD
Metformin—Myalgia—Doxorubicin—hematologic cancer	1.9e-05	0.000106	CcSEcCtD
Metformin—Nausea—Triamcinolone—hematologic cancer	1.89e-05	0.000105	CcSEcCtD
Metformin—Paraesthesia—Methotrexate—hematologic cancer	1.89e-05	0.000105	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.89e-05	0.000105	CcSEcCtD
Metformin—Discomfort—Doxorubicin—hematologic cancer	1.88e-05	0.000105	CcSEcCtD
Metformin—Anorexia—Epirubicin—hematologic cancer	1.88e-05	0.000105	CcSEcCtD
Metformin—Dyspnoea—Methotrexate—hematologic cancer	1.87e-05	0.000105	CcSEcCtD
Metformin—Somnolence—Methotrexate—hematologic cancer	1.87e-05	0.000104	CcSEcCtD
Metformin—Dyspepsia—Methotrexate—hematologic cancer	1.85e-05	0.000103	CcSEcCtD
Metformin—Hypotension—Epirubicin—hematologic cancer	1.84e-05	0.000103	CcSEcCtD
Metformin—Vomiting—Dexamethasone—hematologic cancer	1.84e-05	0.000102	CcSEcCtD
Metformin—Vomiting—Betamethasone—hematologic cancer	1.84e-05	0.000102	CcSEcCtD
Metformin—Decreased appetite—Methotrexate—hematologic cancer	1.83e-05	0.000102	CcSEcCtD
Metformin—Rash—Dexamethasone—hematologic cancer	1.82e-05	0.000102	CcSEcCtD
Metformin—Rash—Betamethasone—hematologic cancer	1.82e-05	0.000102	CcSEcCtD
Metformin—Oedema—Doxorubicin—hematologic cancer	1.82e-05	0.000102	CcSEcCtD
Metformin—Dermatitis—Dexamethasone—hematologic cancer	1.82e-05	0.000101	CcSEcCtD
Metformin—Dermatitis—Betamethasone—hematologic cancer	1.82e-05	0.000101	CcSEcCtD
Metformin—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.82e-05	0.000101	CcSEcCtD
Metformin—Fatigue—Methotrexate—hematologic cancer	1.81e-05	0.000101	CcSEcCtD
Metformin—Headache—Dexamethasone—hematologic cancer	1.81e-05	0.000101	CcSEcCtD
Metformin—Headache—Betamethasone—hematologic cancer	1.81e-05	0.000101	CcSEcCtD
Metformin—Infection—Doxorubicin—hematologic cancer	1.81e-05	0.000101	CcSEcCtD
Metformin—Asthenia—Prednisone—hematologic cancer	1.81e-05	0.000101	CcSEcCtD
Metformin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.79e-05	0.0001	CcSEcCtD
Metformin—Shock—Doxorubicin—hematologic cancer	1.79e-05	9.99e-05	CcSEcCtD
Metformin—Nervous system disorder—Doxorubicin—hematologic cancer	1.79e-05	9.96e-05	CcSEcCtD
Metformin—Thrombocytopenia—Doxorubicin—hematologic cancer	1.78e-05	9.94e-05	CcSEcCtD
Metformin—Pruritus—Prednisone—hematologic cancer	1.78e-05	9.93e-05	CcSEcCtD
Metformin—Skin disorder—Doxorubicin—hematologic cancer	1.77e-05	9.86e-05	CcSEcCtD
Metformin—Paraesthesia—Epirubicin—hematologic cancer	1.77e-05	9.85e-05	CcSEcCtD
Metformin—Hyperhidrosis—Doxorubicin—hematologic cancer	1.76e-05	9.81e-05	CcSEcCtD
Metformin—Dyspnoea—Epirubicin—hematologic cancer	1.75e-05	9.78e-05	CcSEcCtD
Metformin—Somnolence—Epirubicin—hematologic cancer	1.75e-05	9.75e-05	CcSEcCtD
Metformin—Anorexia—Doxorubicin—hematologic cancer	1.74e-05	9.68e-05	CcSEcCtD
Metformin—Feeling abnormal—Methotrexate—hematologic cancer	1.73e-05	9.66e-05	CcSEcCtD
Metformin—Dyspepsia—Epirubicin—hematologic cancer	1.73e-05	9.66e-05	CcSEcCtD
Metformin—Diarrhoea—Prednisone—hematologic cancer	1.72e-05	9.6e-05	CcSEcCtD
Metformin—Gastrointestinal pain—Methotrexate—hematologic cancer	1.72e-05	9.59e-05	CcSEcCtD
Metformin—Nausea—Dexamethasone—hematologic cancer	1.72e-05	9.57e-05	CcSEcCtD
Metformin—Nausea—Betamethasone—hematologic cancer	1.72e-05	9.57e-05	CcSEcCtD
Metformin—Decreased appetite—Epirubicin—hematologic cancer	1.71e-05	9.54e-05	CcSEcCtD
Metformin—Hypotension—Doxorubicin—hematologic cancer	1.7e-05	9.49e-05	CcSEcCtD
Metformin—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.7e-05	9.47e-05	CcSEcCtD
Metformin—Fatigue—Epirubicin—hematologic cancer	1.7e-05	9.46e-05	CcSEcCtD
Metformin—Constipation—Epirubicin—hematologic cancer	1.68e-05	9.38e-05	CcSEcCtD
Metformin—Urticaria—Methotrexate—hematologic cancer	1.67e-05	9.31e-05	CcSEcCtD
Metformin—Dizziness—Prednisone—hematologic cancer	1.66e-05	9.28e-05	CcSEcCtD
Metformin—Abdominal pain—Methotrexate—hematologic cancer	1.66e-05	9.27e-05	CcSEcCtD
Metformin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.66e-05	9.25e-05	CcSEcCtD
Metformin—Paraesthesia—Doxorubicin—hematologic cancer	1.63e-05	9.12e-05	CcSEcCtD
Metformin—Dyspnoea—Doxorubicin—hematologic cancer	1.62e-05	9.05e-05	CcSEcCtD
Metformin—Feeling abnormal—Epirubicin—hematologic cancer	1.62e-05	9.04e-05	CcSEcCtD
Metformin—Somnolence—Doxorubicin—hematologic cancer	1.62e-05	9.03e-05	CcSEcCtD
Metformin—Gastrointestinal pain—Epirubicin—hematologic cancer	1.61e-05	8.97e-05	CcSEcCtD
Metformin—Dyspepsia—Doxorubicin—hematologic cancer	1.6e-05	8.94e-05	CcSEcCtD
Metformin—Vomiting—Prednisone—hematologic cancer	1.6e-05	8.92e-05	CcSEcCtD
Metformin—Rash—Prednisone—hematologic cancer	1.59e-05	8.85e-05	CcSEcCtD
Metformin—Dermatitis—Prednisone—hematologic cancer	1.58e-05	8.84e-05	CcSEcCtD
Metformin—Decreased appetite—Doxorubicin—hematologic cancer	1.58e-05	8.83e-05	CcSEcCtD
Metformin—Headache—Prednisone—hematologic cancer	1.58e-05	8.79e-05	CcSEcCtD
Metformin—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.57e-05	8.76e-05	CcSEcCtD
Metformin—Fatigue—Doxorubicin—hematologic cancer	1.57e-05	8.75e-05	CcSEcCtD
Metformin—Urticaria—Epirubicin—hematologic cancer	1.56e-05	8.72e-05	CcSEcCtD
Metformin—Constipation—Doxorubicin—hematologic cancer	1.56e-05	8.68e-05	CcSEcCtD
Metformin—Abdominal pain—Epirubicin—hematologic cancer	1.56e-05	8.67e-05	CcSEcCtD
Metformin—Asthenia—Methotrexate—hematologic cancer	1.51e-05	8.41e-05	CcSEcCtD
Metformin—Feeling abnormal—Doxorubicin—hematologic cancer	1.5e-05	8.37e-05	CcSEcCtD
Metformin—Nausea—Prednisone—hematologic cancer	1.49e-05	8.33e-05	CcSEcCtD
Metformin—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.49e-05	8.3e-05	CcSEcCtD
Metformin—Pruritus—Methotrexate—hematologic cancer	1.49e-05	8.29e-05	CcSEcCtD
Metformin—Urticaria—Doxorubicin—hematologic cancer	1.45e-05	8.06e-05	CcSEcCtD
Metformin—Abdominal pain—Doxorubicin—hematologic cancer	1.44e-05	8.03e-05	CcSEcCtD
Metformin—Diarrhoea—Methotrexate—hematologic cancer	1.44e-05	8.02e-05	CcSEcCtD
Metformin—Asthenia—Epirubicin—hematologic cancer	1.41e-05	7.87e-05	CcSEcCtD
Metformin—Pruritus—Epirubicin—hematologic cancer	1.39e-05	7.76e-05	CcSEcCtD
Metformin—Dizziness—Methotrexate—hematologic cancer	1.39e-05	7.75e-05	CcSEcCtD
Metformin—Diarrhoea—Epirubicin—hematologic cancer	1.35e-05	7.51e-05	CcSEcCtD
Metformin—Vomiting—Methotrexate—hematologic cancer	1.34e-05	7.45e-05	CcSEcCtD
Metformin—Rash—Methotrexate—hematologic cancer	1.33e-05	7.39e-05	CcSEcCtD
Metformin—Dermatitis—Methotrexate—hematologic cancer	1.32e-05	7.39e-05	CcSEcCtD
Metformin—Headache—Methotrexate—hematologic cancer	1.32e-05	7.34e-05	CcSEcCtD
Metformin—Asthenia—Doxorubicin—hematologic cancer	1.31e-05	7.28e-05	CcSEcCtD
Metformin—Dizziness—Epirubicin—hematologic cancer	1.3e-05	7.26e-05	CcSEcCtD
Metformin—Pruritus—Doxorubicin—hematologic cancer	1.29e-05	7.18e-05	CcSEcCtD
Metformin—Vomiting—Epirubicin—hematologic cancer	1.25e-05	6.98e-05	CcSEcCtD
Metformin—Nausea—Methotrexate—hematologic cancer	1.25e-05	6.96e-05	CcSEcCtD
Metformin—Diarrhoea—Doxorubicin—hematologic cancer	1.25e-05	6.95e-05	CcSEcCtD
Metformin—Rash—Epirubicin—hematologic cancer	1.24e-05	6.92e-05	CcSEcCtD
Metformin—Dermatitis—Epirubicin—hematologic cancer	1.24e-05	6.91e-05	CcSEcCtD
Metformin—Headache—Epirubicin—hematologic cancer	1.23e-05	6.87e-05	CcSEcCtD
Metformin—Dizziness—Doxorubicin—hematologic cancer	1.2e-05	6.71e-05	CcSEcCtD
Metformin—Nausea—Epirubicin—hematologic cancer	1.17e-05	6.52e-05	CcSEcCtD
Metformin—Vomiting—Doxorubicin—hematologic cancer	1.16e-05	6.45e-05	CcSEcCtD
Metformin—Rash—Doxorubicin—hematologic cancer	1.15e-05	6.4e-05	CcSEcCtD
Metformin—Dermatitis—Doxorubicin—hematologic cancer	1.15e-05	6.4e-05	CcSEcCtD
Metformin—Headache—Doxorubicin—hematologic cancer	1.14e-05	6.36e-05	CcSEcCtD
Metformin—Nausea—Doxorubicin—hematologic cancer	1.08e-05	6.03e-05	CcSEcCtD
Metformin—NDUFV2—Metabolism—PIK3CA—hematologic cancer	3.88e-06	2.9e-05	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—PIK3CA—hematologic cancer	3.88e-06	2.9e-05	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—PIK3CA—hematologic cancer	3.88e-06	2.9e-05	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—PIK3CA—hematologic cancer	3.88e-06	2.9e-05	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—PIK3CA—hematologic cancer	3.88e-06	2.9e-05	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—PIK3CA—hematologic cancer	3.88e-06	2.9e-05	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—PIK3CA—hematologic cancer	3.88e-06	2.9e-05	CbGpPWpGaD
Metformin—ND3—Metabolism—PIK3CA—hematologic cancer	3.88e-06	2.9e-05	CbGpPWpGaD
Metformin—ND2—Metabolism—PIK3CA—hematologic cancer	3.88e-06	2.9e-05	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—PIK3CA—hematologic cancer	3.88e-06	2.9e-05	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—PIK3CA—hematologic cancer	3.88e-06	2.9e-05	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—PIK3CA—hematologic cancer	3.88e-06	2.9e-05	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—PIK3CA—hematologic cancer	3.88e-06	2.9e-05	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—PIK3CA—hematologic cancer	3.88e-06	2.9e-05	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—PIK3CA—hematologic cancer	3.88e-06	2.9e-05	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—PIK3CA—hematologic cancer	3.88e-06	2.9e-05	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—PIK3CA—hematologic cancer	3.88e-06	2.9e-05	CbGpPWpGaD
Metformin—ND4L—Metabolism—PIK3CA—hematologic cancer	3.88e-06	2.9e-05	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—PIK3CA—hematologic cancer	3.88e-06	2.9e-05	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—PIK3CA—hematologic cancer	3.88e-06	2.9e-05	CbGpPWpGaD
Metformin—ND5—Metabolism—PIK3CA—hematologic cancer	3.88e-06	2.9e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—FHL2—hematologic cancer	3.81e-06	2.85e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—IDH2—hematologic cancer	3.8e-06	2.84e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—HMMR—hematologic cancer	3.8e-06	2.84e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—CREBBP—hematologic cancer	3.76e-06	2.81e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IL2RA—hematologic cancer	3.76e-06	2.81e-05	CbGpPWpGaD
Metformin—SLC22A3—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.74e-06	2.79e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—AGRN—hematologic cancer	3.74e-06	2.79e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—EP300—hematologic cancer	3.74e-06	2.79e-05	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—AKT1—hematologic cancer	3.73e-06	2.78e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TERT—hematologic cancer	3.72e-06	2.78e-05	CbGpPWpGaD
Metformin—SLC22A2—Neuronal System—MDM2—hematologic cancer	3.71e-06	2.77e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PDGFB—hematologic cancer	3.63e-06	2.71e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ARNTL—hematologic cancer	3.58e-06	2.67e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PIK3CD—hematologic cancer	3.57e-06	2.66e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TSC2—hematologic cancer	3.55e-06	2.65e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—IDH2—hematologic cancer	3.55e-06	2.65e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—HMMR—hematologic cancer	3.55e-06	2.65e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—ALB—hematologic cancer	3.52e-06	2.63e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	3.51e-06	2.62e-05	CbGpPWpGaD
Metformin—SLC22A3—Transmembrane transport of small molecules—ALB—hematologic cancer	3.5e-06	2.62e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ACP5—hematologic cancer	3.48e-06	2.6e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CA9—hematologic cancer	3.48e-06	2.6e-05	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—PIK3CA—hematologic cancer	3.46e-06	2.58e-05	CbGpPWpGaD
Metformin—SLC22A1—Neuronal System—MDM2—hematologic cancer	3.46e-06	2.58e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—NCOR2—hematologic cancer	3.43e-06	2.56e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—FGFR3—hematologic cancer	3.41e-06	2.55e-05	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—AKT1—hematologic cancer	3.41e-06	2.55e-05	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—AKT1—hematologic cancer	3.41e-06	2.55e-05	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—AKT1—hematologic cancer	3.41e-06	2.55e-05	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—AKT1—hematologic cancer	3.41e-06	2.55e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MAPK14—hematologic cancer	3.38e-06	2.52e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PIK3R1—hematologic cancer	3.37e-06	2.52e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ARNTL—hematologic cancer	3.33e-06	2.49e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—NQO1—hematologic cancer	3.32e-06	2.48e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CD44—hematologic cancer	3.32e-06	2.48e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—ESR1—hematologic cancer	3.31e-06	2.47e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	3.27e-06	2.44e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—FN1—hematologic cancer	3.27e-06	2.44e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—IDH1—hematologic cancer	3.27e-06	2.44e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ACP5—hematologic cancer	3.24e-06	2.42e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CA9—hematologic cancer	3.24e-06	2.42e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—BAD—hematologic cancer	3.23e-06	2.41e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NFKBIA—hematologic cancer	3.23e-06	2.41e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—TXN—hematologic cancer	3.23e-06	2.41e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ABCC3—hematologic cancer	3.23e-06	2.41e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTO1—hematologic cancer	3.23e-06	2.41e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NOTCH1—hematologic cancer	3.2e-06	2.39e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NCOR2—hematologic cancer	3.2e-06	2.39e-05	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—AKT1—hematologic cancer	3.17e-06	2.37e-05	CbGpPWpGaD
Metformin—ND2—Metabolism—AKT1—hematologic cancer	3.17e-06	2.37e-05	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—AKT1—hematologic cancer	3.17e-06	2.37e-05	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—AKT1—hematologic cancer	3.17e-06	2.37e-05	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—AKT1—hematologic cancer	3.17e-06	2.37e-05	CbGpPWpGaD
Metformin—ND4L—Metabolism—AKT1—hematologic cancer	3.17e-06	2.37e-05	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—AKT1—hematologic cancer	3.17e-06	2.37e-05	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—AKT1—hematologic cancer	3.17e-06	2.37e-05	CbGpPWpGaD
Metformin—ND6—Metabolism—AKT1—hematologic cancer	3.17e-06	2.37e-05	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—AKT1—hematologic cancer	3.17e-06	2.37e-05	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—AKT1—hematologic cancer	3.17e-06	2.37e-05	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—AKT1—hematologic cancer	3.17e-06	2.37e-05	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—AKT1—hematologic cancer	3.17e-06	2.37e-05	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—AKT1—hematologic cancer	3.17e-06	2.37e-05	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—AKT1—hematologic cancer	3.17e-06	2.37e-05	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—AKT1—hematologic cancer	3.17e-06	2.37e-05	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—AKT1—hematologic cancer	3.17e-06	2.37e-05	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—AKT1—hematologic cancer	3.17e-06	2.37e-05	CbGpPWpGaD
Metformin—ND4—Metabolism—AKT1—hematologic cancer	3.17e-06	2.37e-05	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—AKT1—hematologic cancer	3.17e-06	2.37e-05	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—AKT1—hematologic cancer	3.17e-06	2.37e-05	CbGpPWpGaD
Metformin—ND3—Metabolism—AKT1—hematologic cancer	3.17e-06	2.37e-05	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—AKT1—hematologic cancer	3.17e-06	2.37e-05	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—AKT1—hematologic cancer	3.17e-06	2.37e-05	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—AKT1—hematologic cancer	3.17e-06	2.37e-05	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—AKT1—hematologic cancer	3.17e-06	2.37e-05	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—AKT1—hematologic cancer	3.17e-06	2.37e-05	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—AKT1—hematologic cancer	3.17e-06	2.37e-05	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—AKT1—hematologic cancer	3.17e-06	2.37e-05	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—AKT1—hematologic cancer	3.17e-06	2.37e-05	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—AKT1—hematologic cancer	3.17e-06	2.37e-05	CbGpPWpGaD
Metformin—ND5—Metabolism—AKT1—hematologic cancer	3.17e-06	2.37e-05	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—AKT1—hematologic cancer	3.17e-06	2.37e-05	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—AKT1—hematologic cancer	3.17e-06	2.37e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—SPHK1—hematologic cancer	3.17e-06	2.36e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CYCS—hematologic cancer	3.14e-06	2.35e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CD80—hematologic cancer	3.14e-06	2.34e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CG—hematologic cancer	3.13e-06	2.34e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—KIT—hematologic cancer	3.13e-06	2.34e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—HSP90AA1—hematologic cancer	3.12e-06	2.33e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PIK3CB—hematologic cancer	3.11e-06	2.32e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PTPN11—hematologic cancer	3.08e-06	2.3e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—IDH1—hematologic cancer	3.05e-06	2.28e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—UGT1A1—hematologic cancer	3.04e-06	2.27e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ABCC3—hematologic cancer	3.01e-06	2.25e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTO1—hematologic cancer	3.01e-06	2.25e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—TXN—hematologic cancer	3.01e-06	2.25e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CREB1—hematologic cancer	2.98e-06	2.23e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CRABP1—hematologic cancer	2.96e-06	2.21e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—SLC22A1—hematologic cancer	2.96e-06	2.21e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—SPHK1—hematologic cancer	2.95e-06	2.2e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—BRAF—hematologic cancer	2.94e-06	2.2e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PIK3CA—hematologic cancer	2.94e-06	2.2e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PIK3CA—hematologic cancer	2.94e-06	2.2e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PIK3CA—hematologic cancer	2.94e-06	2.2e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CCL2—hematologic cancer	2.92e-06	2.18e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IL6R—hematologic cancer	2.91e-06	2.17e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CREBBP—hematologic cancer	2.9e-06	2.17e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ALOX5—hematologic cancer	2.88e-06	2.15e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—UGT1A1—hematologic cancer	2.83e-06	2.12e-05	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—AKT1—hematologic cancer	2.83e-06	2.11e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—NUP98—hematologic cancer	2.79e-06	2.08e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MAP2K1—hematologic cancer	2.77e-06	2.07e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GSTP1—hematologic cancer	2.77e-06	2.07e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PIK3CA—hematologic cancer	2.77e-06	2.07e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CRABP1—hematologic cancer	2.76e-06	2.06e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CD—hematologic cancer	2.75e-06	2.06e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—NCOA3—hematologic cancer	2.71e-06	2.02e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ADCY7—hematologic cancer	2.71e-06	2.02e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—NUP214—hematologic cancer	2.69e-06	2.01e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PTEN—hematologic cancer	2.69e-06	2.01e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ALOX5—hematologic cancer	2.69e-06	2.01e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmission across Chemical Synapses—HRAS—hematologic cancer	2.66e-06	1.98e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—FGF2—hematologic cancer	2.64e-06	1.97e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ABCG2—hematologic cancer	2.64e-06	1.97e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—MTR—hematologic cancer	2.64e-06	1.97e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ABCB1—hematologic cancer	2.62e-06	1.96e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NUP98—hematologic cancer	2.6e-06	1.94e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3R1—hematologic cancer	2.6e-06	1.94e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ENO2—hematologic cancer	2.59e-06	1.93e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—EP300—hematologic cancer	2.56e-06	1.91e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—NCOR1—hematologic cancer	2.55e-06	1.9e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GSTM1—hematologic cancer	2.55e-06	1.9e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—JAK2—hematologic cancer	2.53e-06	1.89e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NCOA3—hematologic cancer	2.53e-06	1.89e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ADCY7—hematologic cancer	2.53e-06	1.89e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NUP214—hematologic cancer	2.51e-06	1.87e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTT1—hematologic cancer	2.51e-06	1.87e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmission across Chemical Synapses—HRAS—hematologic cancer	2.48e-06	1.85e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MDM2—hematologic cancer	2.47e-06	1.84e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—MTR—hematologic cancer	2.46e-06	1.83e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ABCG2—hematologic cancer	2.46e-06	1.83e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—SDC1—hematologic cancer	2.45e-06	1.83e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ENO2—hematologic cancer	2.41e-06	1.8e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—AKT1—hematologic cancer	2.4e-06	1.79e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—AKT1—hematologic cancer	2.4e-06	1.79e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—AKT1—hematologic cancer	2.4e-06	1.79e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CB—hematologic cancer	2.4e-06	1.79e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MTOR—hematologic cancer	2.4e-06	1.79e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.35e-06	1.75e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTT1—hematologic cancer	2.34e-06	1.75e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—SDC1—hematologic cancer	2.28e-06	1.71e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—AKT1—hematologic cancer	2.26e-06	1.69e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CDKN1B—hematologic cancer	2.25e-06	1.68e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—MTHFR—hematologic cancer	2.25e-06	1.68e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CASP3—hematologic cancer	2.21e-06	1.65e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IL2—hematologic cancer	2.2e-06	1.65e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—ALB—hematologic cancer	2.2e-06	1.64e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.19e-06	1.63e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CCND1—hematologic cancer	2.15e-06	1.6e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—JUN—hematologic cancer	2.14e-06	1.6e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—NQO1—hematologic cancer	2.08e-06	1.56e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CD44—hematologic cancer	2.08e-06	1.56e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CDKN1A—hematologic cancer	2.08e-06	1.55e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PTEN—hematologic cancer	2.07e-06	1.55e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—ALB—hematologic cancer	2.05e-06	1.53e-05	CbGpPWpGaD
Metformin—SLC22A2—Neuronal System—HRAS—hematologic cancer	2.04e-06	1.52e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MAPK8—hematologic cancer	2.03e-06	1.51e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—EP300—hematologic cancer	1.98e-06	1.48e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYCS—hematologic cancer	1.97e-06	1.47e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—HSP90AA1—hematologic cancer	1.96e-06	1.46e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CD44—hematologic cancer	1.94e-06	1.45e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NQO1—hematologic cancer	1.94e-06	1.45e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—SRC—hematologic cancer	1.92e-06	1.44e-05	CbGpPWpGaD
Metformin—SLC22A1—Neuronal System—HRAS—hematologic cancer	1.9e-06	1.42e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PIK3CA—hematologic cancer	1.9e-06	1.42e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CG—hematologic cancer	1.89e-06	1.41e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—VEGFA—hematologic cancer	1.87e-06	1.4e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—STAT3—hematologic cancer	1.86e-06	1.38e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NRAS—hematologic cancer	1.85e-06	1.38e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYCS—hematologic cancer	1.84e-06	1.37e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—HSP90AA1—hematologic cancer	1.83e-06	1.36e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MAPK3—hematologic cancer	1.77e-06	1.32e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CREBBP—hematologic cancer	1.75e-06	1.31e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTP1—hematologic cancer	1.74e-06	1.3e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MYC—hematologic cancer	1.72e-06	1.29e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TGFB1—hematologic cancer	1.72e-06	1.28e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CD—hematologic cancer	1.66e-06	1.24e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ABCB1—hematologic cancer	1.65e-06	1.23e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ALB—hematologic cancer	1.64e-06	1.23e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTP1—hematologic cancer	1.62e-06	1.21e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTM1—hematologic cancer	1.6e-06	1.19e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—NCOR1—hematologic cancer	1.6e-06	1.19e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—KRAS—hematologic cancer	1.59e-06	1.19e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3R1—hematologic cancer	1.57e-06	1.17e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—AKT1—hematologic cancer	1.55e-06	1.16e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ABCB1—hematologic cancer	1.53e-06	1.14e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NCOR1—hematologic cancer	1.49e-06	1.11e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTM1—hematologic cancer	1.49e-06	1.11e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CA—hematologic cancer	1.46e-06	1.09e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CB—hematologic cancer	1.45e-06	1.08e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TP53—hematologic cancer	1.42e-06	1.06e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—MTHFR—hematologic cancer	1.41e-06	1.05e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—HRAS—hematologic cancer	1.35e-06	1.01e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—MTHFR—hematologic cancer	1.32e-06	9.82e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IL6—hematologic cancer	1.3e-06	9.67e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PTEN—hematologic cancer	1.25e-06	9.35e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—AKT1—hematologic cancer	1.2e-06	8.92e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—EP300—hematologic cancer	1.19e-06	8.91e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CG—hematologic cancer	1.19e-06	8.85e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CG—hematologic cancer	1.11e-06	8.25e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CREBBP—hematologic cancer	1.1e-06	8.21e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CD—hematologic cancer	1.04e-06	7.78e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ALB—hematologic cancer	1.03e-06	7.68e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CREBBP—hematologic cancer	1.03e-06	7.65e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3R1—hematologic cancer	9.85e-07	7.35e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CD—hematologic cancer	9.72e-07	7.26e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ALB—hematologic cancer	9.59e-07	7.16e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3R1—hematologic cancer	9.18e-07	6.85e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CB—hematologic cancer	9.09e-07	6.79e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CA—hematologic cancer	8.83e-07	6.59e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CB—hematologic cancer	8.47e-07	6.32e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PTEN—hematologic cancer	7.85e-07	5.86e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—EP300—hematologic cancer	7.49e-07	5.59e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PTEN—hematologic cancer	7.32e-07	5.46e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—AKT1—hematologic cancer	7.22e-07	5.39e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—EP300—hematologic cancer	6.98e-07	5.21e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CA—hematologic cancer	5.54e-07	4.14e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CA—hematologic cancer	5.16e-07	3.86e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—AKT1—hematologic cancer	4.53e-07	3.38e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—AKT1—hematologic cancer	4.22e-07	3.15e-06	CbGpPWpGaD
